The role of interleukin-8 in interstitial pneumonia

Respirology

Volumn 8, Issue 1, 2003, Pages 33-40

  Fujimori, Yoshiaki ^a   Kataoka, Mikio ^a   Tada, Shinya ^a   Takehara, Hideki ^a   Matsuo, Kiyoshi ^a   Miyake, Toshitsugu ^a   Okahara, Masayuki ^a   Yamadori, Ichiro ^b   Tanimoto, Mitsune ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION OKAYAMA MEDICAL CENTER   (Japan)

Author keywords

Bronchoalveolar lavage; Collagen vascular disease; Idiopathic interstitial pneumonia; Immunohistochemical staining; Interleukin 8; Non specific interstitial pneumonia; Usual interstitial pneumonia

Indexed keywords

COLLAGEN; INTERLEUKIN 8;

ALLERGIC PNEUMONITIS; ARTICLE; CELL DENSITY; CELL TYPE; CELLULAR DISTRIBUTION; COLLAGEN DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LUNG; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MACROPHAGE; MAJOR CLINICAL STUDY; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SARCOIDOSIS; VASCULAR DISEASE;

AIRWAY RESISTANCE; BIOPSY, NEEDLE; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERLEUKIN-8; LUNG DISEASES, INTERSTITIAL; MALE; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0037366284     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2003.00420.x     Document Type: Article

References (21)

1. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N. Engl. J. Med. 1984; 310: 235-44.
2. Hunninghake GW, Gadek JE, Lawley TJ, Crystal RG. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J. Clin. Invest. 1981; 68: 259-69.
3. TBCGS Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am. Rev. Respir. Dis. 1990; 141: S169-202.
4. Haslam PL, Turton CW, Heard B et al. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax 1980; 35: 9-18.
5. Daniele RP, Elias JA, Epstein PE, Rossman MD. Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease. Ann. Intern. Med. 1985; 102: 93-108.
6. Watters LC, Schwarz MI, Cherniack RM et al. Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am. Rev. Respir. Dis. 1987; 135: 696-704.
7. Turner-Warwick M, Haslam PL. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am. Rev. Respir. Dis. 1987; 135: 26-34.
8. Matsushima K, Morishita K, Yoshimura T et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med. 1988; 167: 1883-93.
9. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 1989; 84: 1045-9.
10. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp. Lung. Res. 1991; 17: 17-23.
11. Schroder JM, Christophers E. Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J. Invest. Dermatol. 1986; 87: 53-8.
12. Seitz M, Dewald B, Gerber N, Baggiolini M. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J. Clin. Invest. 1991; 87: 463-9.
13. Jorens PG, Van Damme J, De Backer W et al. Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine 1992; 4: 592-7.
14. Van Zee KJ, DeForge LE, Fischer E et al. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J. Immunol. 1991; 146: 3478-82.
15. Rennard SI, Basset G, Lecossier D et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 1986; 60: 532-8.
16. Standiford TJ, Kunkel SL, Basha MA et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J. Clin. Invest. 1990; 86: 1945-53.
17. Strieter RM, Phan SH, Showell HJ et al. Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J. Biol. Chem. 1989; 264: 10621-6.
18. Strieter RM, Kunkel SL, Showell HJ et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science 1989; 243: 1467-9.
19. Lynch JP 3rd, Standiford TJ, Rolfe MW, Kunkel SL, Strieter RM. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am. Rev. Respir. Dis. 1992; 145: 1433-9.
20. Southcott AM, Jones KP, Li D et al. Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis. Am. J. Respir. Crit. Care Med. 1995; 151: 1604-12.
21. Carre PC, Mortenson RL, King TE Jr, Noble PW, Sable CL, Riches DW. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J. Clin. Invest. 1991; 88: 1802-10.